60 DEGREES PHARMACEUTICALS, INC. (SXTP)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- None
- No Form 4 sale on record
- Form 4 sales
- 0
- On record
- Form 144 notices
- 0
- Proposed sales
- Sold, last 30 days
- None
- No Form 4 sale
- Sold, last 90 days
- None
- No Form 4 sale
- Next unlock
- None
- No lockup ahead
Lockups
None ahead
Every lockup on record has ended.
- LockupAssumed dateOct 13, 2025 405 days ago
90 days from Jul 15, 2025.
Sales by reason
No Form 4 sale on record.
Timeline
- Oct 13, 2025Lockup ends, assumed
Lockup assumed to end Oct 13, 2025
1 of 1
Every transaction
| Traded | Filed | Stock | Name | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | Jun 15, 2026 | SXTP | Dow Geoffrey S | President and CEO | Bought | 7,350 | $1.38 | $10k | 24,131 | SEC |
| Dec 15, 2025 | Dec 16, 2025 | SXTP | Dow Geoffrey S | President and CEO | Bought | 9,670 | $0.80 | $8k | 59,618 | SEC |
| Dec 11, 2025 | Dec 12, 2025 | SXTP | Dow Geoffrey S | President and CEO | Bought | 12,963 | $0.94 | $12k | 49,948 | SEC |
| Sep 12, 2025 | Sep 15, 2025 | SXTP | Dow Geoffrey S | President and CEO | Awarded | 7,201 | $1.39 | $10k | 33,372 | SEC |
| Jun 9, 2025 | Jun 9, 2025 | SXTP | Dow Geoffrey S | President and CEO | Awarded | 4,376 | $2.99 | $13k | 26,171 | SEC |
| Jun 3, 2025 | Jun 5, 2025 | SXTP | Xu Cheryl | Director | Bought | 5,000 | $2.88 | $14k | 15,816 | SEC |
| Jan 17, 2025 | Aug 14, 2025 | SXTP | Landon Kristen | Chief Operating Officer | Awarded | 4,540 | 4,540 | SEC | ||
| Jan 17, 2025 | Jan 21, 2025 | SXTP | Dow Geoffrey S | President and CEO | Awarded | 14,394 | 108,974 | SEC | ||
| Jan 17, 2025 | Jan 21, 2025 | SXTP | Miller Tyrone | CFO | Awarded | 11,626 | 26,370 | SEC | ||
| Jan 2, 2025 | Jan 24, 2025 | SXTP | Dow Geoffrey S | President and CEO | AwardedStock Option (Right to Buy) | 525,000 | 525,000 | SEC | ||
| Jan 2, 2025 | Jan 24, 2025 | SXTP | Miller Tyrone | CFO | AwardedStock Option (Right to Buy) | 75,000 | 75,000 | SEC | ||
| Dec 16, 2024 | Dec 18, 2024 | SXTP | Xu Cheryl | Director | Bought | 13,000 | $1.65 | $21k | 54,078 | SEC |
| Dec 9, 2024 | Dec 9, 2024 | SXTP | Dow Geoffrey S | President and CEO | Bought | 73,951 | $1.21 | $90k | 94,580 | SEC |
| Nov 21, 2024 | Nov 21, 2024 | SXTP | Dow Geoffrey S | President and CEO | Bought | 7,000 | $0.91 | $6k | 20,629 | SEC |
| Sep 26, 2024 | Aug 14, 2025 | SXTP | Landon Kristen | Chief Operating Officer | AwardedStock Options (Right to Buy) | 4,167 | 4,167 | SEC | ||
| Aug 27, 2024 | Sep 11, 2024 | SXTP | Xu Cheryl | Director | Bought | 5,000 | $1.70 | $9k | 41,078 | SEC |
| May 16, 2024 | May 21, 2024 | SXTP | Xu Cheryl | Director | Exercised or settledRestricted Stock Unit | 2,000 | 0 | SEC | ||
| May 16, 2024 | May 21, 2024 | SXTP | Xu Cheryl | Director | Exercised options | 2,000 | $0.22 | $440 | 228,934 | SEC |
| May 16, 2024 | May 21, 2024 | SXTP | Toovey Stephen | Director | Exercised or settledRestricted Stock Units | 4,000 | 4,000 | SEC | ||
| May 16, 2024 | May 21, 2024 | SXTP | Toovey Stephen | Director | Awarded | 4,000 | $0.22 | $880 | 14,000 | SEC |
| May 16, 2024 | May 21, 2024 | SXTP | Miller Tyrone | CFO | Exercised or settledRestricted Stock Units | 75,000 | 0 | SEC | ||
| May 16, 2024 | May 21, 2024 | SXTP | Miller Tyrone | CFO | Awarded | 75,000 | $0.26 | $20k | 176,928 | SEC |
| May 16, 2024 | May 21, 2024 | SXTP | Field Paul | Director | Exercised or settledRestricted Stock Units | 4,000 | 4,000 | SEC | ||
| May 16, 2024 | May 21, 2024 | SXTP | Field Paul | Director | Exercised options | 4,000 | $0.22 | $880 | 14,000 | SEC |
| May 16, 2024 | May 21, 2024 | SXTP | Dow Geoffrey S | President and CEO | Exercised or settledRestricted Stock Units | 85,000 | 0 | SEC | ||
| May 16, 2024 | May 21, 2024 | SXTP | Dow Geoffrey S | President and CEO | Exercised options | 85,000 | $0.26 | $22k | 762,625 | SEC |
| May 16, 2024 | May 21, 2024 | SXTP | Allen Charles W | Director | Exercised or settledRestricted Stock Units | 4,000 | 4,000 | SEC | ||
| May 16, 2024 | May 21, 2024 | SXTP | Allen Charles W | Director | Exercised options | 4,000 | $0.22 | $880 | 14,000 | SEC |
| Feb 1, 2024 | Feb 2, 2024 | SXTP | Xu Cheryl | Director | Exercised options | 2,000 | 6,000 | SEC | ||
| Jan 31, 2024 | Feb 2, 2024 | SXTP | Dow Geoffrey S | President and CEO | BoughtWarrant | 25,974 | $0.0100 | $260 | 25,974 | SEC |
| Jan 31, 2024 | Feb 2, 2024 | SXTP | Dow Geoffrey S | President and CEO | Bought | 25,974 | $0.38 | $10k | 703,599 | SEC |
| Jan 31, 2024 | Feb 2, 2024 | SXTP | Xu Cheryl | Director | BoughtWarrant | 200,000 | $0.0100 | $2k | 200,000 | SEC |
| Jan 31, 2024 | Feb 2, 2024 | SXTP | Xu Cheryl | Director | Bought | 200,000 | $0.38 | $76k | 424,934 | SEC |
| Dec 31, 2023 | May 21, 2024 | SXTP | Toovey Stephen | Director | AwardedRestricted Stock Units | 4,000 | 4,000 | SEC | ||
| Dec 31, 2023 | May 21, 2024 | SXTP | Field Paul | Director | AwardedRestricted Stock Units | 4,000 | 4,000 | SEC | ||
| Dec 31, 2023 | May 21, 2024 | SXTP | Allen Charles W | Director | AwardedRestricted Stock Units | 4,000 | 4,000 | SEC | ||
| Nov 21, 2023 | May 21, 2024 | SXTP | Miller Tyrone | CFO | AwardedRestricted Stock Units | 75,000 | 75,000 | SEC | ||
| Nov 21, 2023 | May 21, 2024 | SXTP | Dow Geoffrey S | President and CEO | AwardedRestricted Stock Units | 85,000 | 85,000 | SEC | ||
| Jul 28, 2023 | Apr 3, 2024 | SXTP | Knight Therapeutics International Sa | Other | Converted | 47,722 | $4.53 | $216k | 78,803 | SEC |
| Jul 12, 2023 | Jul 12, 2023 | SXTP | Miller Tyrone | Chief Financial Officer | AwardedNon-Qualified Stock Options (right to buy) | 240,000 | 240,000 | SEC | ||
| Jul 12, 2023 | Jul 12, 2023 | SXTP | Dow Geoffrey S | President and CEO | AwardedNon-Qualified Stock Option (right to buy) | 300,000 | 300,000 | SEC |